Dabur India, in its
bid to expand its consumer care business, is likely to acquire Fem Care Pharma
for about Rs.300 crore and both the companies are likely to sign agreement to
this effect by end-November 2008.
It is learnt that KPMG
is the advisor for the deal. The other companies that were in the race to bid
for Fame Care were Godrej Group and Marico.
Also See:
Dabur India's UAE
plant to commence production by December(10-Oct-08)